Government Pension Fund Global (Norway) decreased its stake in Sun Pharmaceutical Industries Limited from 1.06% to 1.03%, selling 768,073 shares. The shares were valued at approximately ₹147.59 Cr based on a share price of ₹1921.40 apiece.
A leading pharmaceutical manufacturer engaged in developing and marketing branded and generic formulations alongside Active Pharma Ingredients across global markets. The company operates multiple manufacturing facilities worldwide, serving customers through its extensive distribution network. Sun Pharma specializes in therapeutic areas including ophthalmology, cardiology, gastroenterology, and dermatology, combining research-driven innovation with broad-based generics production to serve patients in India and internationally.
Norway's sovereign wealth fund, managed by Norges Bank Investment Management. World's largest SWF with over USD 2 trillion in assets, invested across 8,700+ companies globally including Indian equities.
